Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease

Journal of Lipid Research

Volumn 37, Issue 12, 1996, Pages 2627-2637

  Yang, Wei Shiung ^a   Nevin, David N ^a   Iwasaki, Lori ^a   Peng, Reiling ^a   Brown, B Greg ^a   Brunzell, John D ^a   Deeb, Samir S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

5' untranslated region; FCHL; LPL; promoter

Indexed keywords

LIPOPROTEIN LIPASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CELL TYPE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ENZYME REGULATION; FAMILIAL DISEASE; FEMALE; GENE INSERTION; GENE MUTATION; GENETIC TRANSFECTION; HETEROZYGOSITY; HUMAN; HYDROLYSIS; HYPERLIPIDEMIA; MALE; PRIORITY JOURNAL; PROMOTER REGION;

CORONARY DISEASE; FEMALE; GENES, REGULATOR; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEIN LIPASE; MALE; MUTATION; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA;

EID: 0030452127     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Santamarina-Fojo, S., and K. A. Dugi. 1994. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr. Opin. Lipidol. 5: 117-125.
2. Enerback, S., and J. M. Gimble. 1993. Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochem. Biophys. Acta. 1169: 107-125.
3. Santamarina-Fojo, S. 1992. Genetic dyslipoproteinemia: role of lipoprotein lipase or lipoprotein C-II. Curr. Opin. Lipidol. 3: 186-195.
4. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndrome. In The Metabolic and Molecular Basis of Inherited Disease. 7th ed. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York, 1913-1932.
5. Wilson, D. E., C. Q. Edwards, and I-F. Chan. 1983. Phenotypic heterogeneity in the extended pedigree of a pro band with lipoprotein lipase deficiency. Metabolism. 32: 1107-1114.
6. Wilson, D. E., M. Emi, P-H. Iverius, A. Hata, L. L. Wu, E. Hillas, R. R. Williams, and J. M. Lalouel. 1990. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J. Clin. Invest. 86: 735-750.
7. Babirak, G., B. G. Brown, and J. D. Brunzell. 1992. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler. Thromb. 12: 1176-1183.
8. Miesenbock, G., B. Hoelzl, B. Foeger, E. Brandstaetter, B. Paulweber, F. Sandhofer, and J. R. Patsch. 1993. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J. Clin. Invest. 91: 448-455.
9. Reymer, P. W. A., E. Gagné, B. E. Groenemeyer, H. Zhang, I. Forsyth, H. Jansen, J. C. Seidell, D. Kromhout, K. I. Lie, and J. J. P. Kastelein. 1995. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet. 10: 28-34.
10. Reymer, P. W. A., B. E. Groenemeyer, E. Gagné, L. Miao, E. E. G. Appelman, J. C. Seidell, D. Kromhout, S. M. Bijvoet, K. van de Oever, T. Bruin, M. R. Hayden, and J. J. P. Kastelein. 1995. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum. Mol. Genet. 4: 1543-1549.
11. Goldstein, J. R., W. R. Hazzard, H. G. Schrott, G. L. Bierman, and A. G. Motulsky. 1973. Hyperlipidemia in coronary heart disease II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder combined hyperlipidemia. J. Clin. Invest. 52: 1544-1568.
12. Nikkila, E. A., and A. Aro. 1973. Family study of lipids and lipoproteins in coronary heart disease. Lancet. 1:954-958.
13. Rose, H. G., P. Kranz, M. Weinstock, J. Juliano, and J. I. Haft. 1973. Inheritance of combined hyperlipidemia: evidence of a new lipoprotein phenotype. Am. J. Med. 54: 148-160.
14. Grundy, S. M., A. Ghait, and J. D. Brunzell. 1987. Familial combined hyperlipidemia workshop. Atherosclerosis. 7: 203-207.
15. Brunzell, J. D., M. A. Austin, S. S. Deeb, J. E. Hokanson, G. P. Jarvik, D. N. Nevin, E. Wijsman, A. Zambon, and A. G. Moltulsky. 1995. Familial combined hyperlipidemia and genetic risk for atherosclerosis. In Atherosclerosis X. F. P. Woodford, J. Davignon, and A. Sniderman, editors, Elsevier Science BV, Amsterdam, Netherlands. 624-627.
16. Jarvik, G. P., J. D. Brunzell, M. A. Austin, R. M. Krauss, A. G. Moltulsky, and E. Wijsman. 1994. Genetic predictors of FCHL in four large pedigrees: influence of apoB level major locus predicted genotype and LDL subclass phenotype. Arterioscler. Thromb. 14: 1687-1694.
17. Nevin, D. N., J. D. Brunzell, and S. S. Deeb. 1994. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity. Arterioscler. Thromb. 14: 869-873.
18. Gagné, E., J. Genest, Jr., H. Zhang, L. A. Clarke, and M. R. Hayden. 1994. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler. Thromb. 14: 1250-1257.
19. Yang, W-S., D. N. Nevin, R. Peng, J. D. Brunzell, and S. S. Deeb. 1995. A mutation in the promoter of the lipoprotein lipase gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc. Natl. Acad. Sci. USA. 92: 4462-4466.
20. Yang, W-S., D. N. Nevin, R. Peng, J. D. Brunzell, and S. S. Deeb. 1996. A mutation in the promoter of the lipoprotein lipase gene in a patient with familial combined hyperlipidemia and low LPL activity (erratum). Proc. Natl. Acad. Sci. USA. 93: 524.
21. Deeb, S. S., and R. Peng. 1989. Structure of the human lipoprotein lipase gene. Biochemistry. 28: 4131-4135.
22. Kretz, K. A., G. S. Carson, and J. S. O'Brien. 1989. Direct sequencing from low-melt agarose with sequenase. Nucleic Acids Res. 17: 5864.
23. Nordeen, S. K. 1988. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 6: 454-457.
24. Auwerx, J. H., S. S. Deeb, J. D. Brunzell, R. Peng, and A. Chait. 1988. Transcriptional activation of the lipoprotein lipase and apolipoprotein E genes accompanies differentiation in some human macrophage-like cell lines. Biochemistry. 27: 2651-2655.
25. Wu, H., K. Moulton, A. Horvai, S. Parik, and C. K. Glass. 1994. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol. Cell. Biol. 14: 2129-2139.
26. de Wet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 14: 725-737.
27. Fukuchi, K., M. G. Hearn, S. S. Deeb, A. C. Smith, N. Dang, J. Miyazaki, M. Bothwell, and G. M. Martin. 1994. Activity assays of nine heterogeneous promoters in neural and other cultured cells. In Vitro Cell. Dev. Biol. Anim. 30A: 300-305.
28. Bradford, M. M. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
29. Rastinejad, F., and H. M. Blau. 1993. Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation. Cell. 72: 903-917.
30. Richardson, J. M., and J. E. Pessin. 1993. Identification of a skeletal muscle-specific regulatory domain in the rat GLU4/muscle-fat gene. J. Biol. Chem. 268: 21021-21027.
31. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52: 456-467.
32. Lohse, P., O. U. Beg, J. D. Brunzell, S. Santamarina-Fojo, and H. B. Brewer. 1991. Familial chylomicronemia: identification of a unique patient homozygous for two separate mutations in the LPL gene. Circulation. 84(suppl II): II-376.
33. Faustinella, F., A. Chang, J. P. van Biervlieu, M. Rosseneu, N. Vinaimont, L. C. Smith, S-H. Chen, and L. Chan. 1991. Catalytic triad residue mutation (Asp156 → Gly) causing familial lipoprotein lipase deficiency. J. Biol. Chem. 266: 14418-14424.
34. Hua, X. X., S. Enerback, J. Hudson, K. Youkhana, and J. M. Gimble. 1991. Cloning and characterization of the promoter of the murine lipoprotein lipase-encoding gene: structural and functional analysis. Gene. 107: 247-258.
35. Cooper, D. A., S. C. Lu, R. Viewanath, R. N. Freiman, and A. Bensadoun. 1992. The structure and complete nucleotide sequence of the avian lipoprotein lipase gene. Biochim. Biophys. Acta. 1129: 166-171.
36. Sheng, M., S. Dougan, G. McFadden, and M. E. Greenberg. 1988. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol. Cell. Biol. 8: 2787-2795.
37. Previato, L., C. L. Parrott, S. Santamarina-Fojo, and H. B. Brewer, Jr. 1991. Transcriptional regulation of the human lipoprotein lipase in 3T3-L1 adipocytes. J. Biol. Chem. 266: 18958-18963.
38. Enerback, S., B. G. Ohlsson, L. Samuelsson, and G. Bjursell. 1991. Characterization of the human lipoprotein lipase (LPL) promoter. Evidence of two cis-regulatory regions, LP-α and LP-β, of importance for the differentiation-linked induction of the LPL gene during adipogenesis. Mol. Cell. Biol. 12: 4622-4633.
39. Tanuma, Y., H. Nakabayashi, M. Esumi, and H. Endo. 1995. A silencer element for the lipoprotein lipase gene promoter and cognate double- and single-stranded DNA-binding proteins. Mol. Cell. Biol. 15: 517-523.
40. Ma, Y., T. G. Ooi, M. S. Liu, H. Zhang, R. McPherson, A. L. Edwards, I. J. Forsythe, J. Frohlich, J. D. Brunzell, and M. R. Hayden. 1995. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J. Lipid Res. 35: 1066-1075.
41. Julien, P., M. G. Vohl, G. Lévesque, J. P. Després, M. R. V. Murthy, C. Gagné, D. Gaudet, D. Brun, F. Cadelis, S. Moorjani, and P. J. Lupien. 1995. Effect of obesity on plasma triglyceride levels in familial lipoprotein lipase deficiency. Atherosclerosis. 115(Suppl): S8.
42. Berg, P. E., M. Mittelman, J. Elion, D. Labie, and A. N. Schechter. 1991. Increased protein binding to a -530 mutation of the human globin gene associated with decreased beta-globin synthesis. Am. J. Hematol. 36: 42-47.
43. Cooper, D. N. 1992. Regulatory mutations and human genetic disease. Ann. Med. 24: 427-437.
44. Efremov, D. G., A. J. Dimovski, and T. H. Huisman. 1994. The -158 (C → T) promoter mutation is responsible for the increased transcription for the 3′ gamma gene in the Atlanta type of hereditary persistence of fetal hemoglobin. Blood. 83: 3350-3355.
45. Crossley, M., and G. G. Brownlee. 1990. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature (London) 345: 444-446.
46. Crossley, M., M. Ludwig, K. M. Stowell, P. De Vos, K. Olek, and G. G. Brownlee. 1992. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science. 257: 377-379.
47. Sakai, T., N. Ohtani, T. L. McGee, P. D. Robbins, and T. P. Dryja. 1991. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature (London) 353: 83-86.
48. Koivisto, U-M. J. J. Palvimo, O. A. Janne, and K. Kontula. 1994. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 91: 10526-10530.